In fact, blocking the CSF-1/CSF-1R axis results in a decrease in CD4+ Foxp3+ Tregs correlated with a reduction in tumor growth [22] and enhances CD8+ T cell-mediated immunity in the sarcoma TME [23]. The gene discussed is CSF1R; the disease is sarcoma.